captopril has been researched along with erythrosine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engler, CB; Larsen, M; Lund-Andersen, H; Mathiesen, ER; Parving, HH | 1 |
Hommel, E; Larsen, M; Lund-Andersen, H; Parving, HH | 2 |
Molteni, A; Taylor, JM; Ward, WF; Waters, CM | 1 |
Higgins, RD; Tadesse, M; Yan, Y; Yossuck, P | 1 |
Erinola, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
2 trial(s) available for captopril and erythrosine
Article | Year |
---|---|
Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
Topics: Adult; Albuminuria; Blood-Retinal Barrier; Captopril; Cell Membrane Permeability; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein; Fluorescein Angiography; Fluoresceins; Fluorophotometry; Humans; Hypertension; Male; Middle Aged | 1991 |
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Topics: Adult; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Hemoglobin C; Humans; Male; Permeability; Prospective Studies | 1990 |
4 other study(ies) available for captopril and erythrosine
Article | Year |
---|---|
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Furosemide; Glomerular Filtration Rate; Humans; Male; Middle Aged | 1989 |
Dose-response effects of radiation on the permeability of endothelial cells in culture.
Topics: Actins; Animals; Captopril; Catalase; Cattle; Cell Membrane Permeability; Cells, Cultured; Cesium Radioisotopes; Cytoskeleton; Dose-Response Relationship, Radiation; Endothelium, Vascular; Fluorescein; Fluoresceins; Gamma Rays; Kinetics; L-Lactate Dehydrogenase; Pulmonary Artery; Time Factors; Vitamin B 12 | 1996 |
Captopril improves retinal neovascularization via endothelin-1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dextrans; Endothelin-1; Fluorescein Angiography; Fluoresceins; Fundus Oculi; Hyperoxia; Mice; Mice, Inbred C57BL; Perfusion; Retinal Neovascularization; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Captopril and quinapril reduce reactive oxygen species.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Fluoresceins; Fluorescent Dyes; Humans; Isoquinolines; Leukocytes, Mononuclear; Lisinopril; NADPH Oxidases; Quinapril; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines | 2002 |